Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits
Nicholas Govsyeyev, Mark R. Nehler, Michael S. Conte, Sebastian Debus, Jayer Chung, Walter Dorigo, Ivan Gudz, Dainis Krieviņš, Joseph L. Mills, Frans L. Moll, Lars Norgren, Gabriele Piffaretti, Rick Powell, David Szalay, Henrik Sillesen, Max V. Wohlauer, Michael Szarek, Rupert Bauersachs, Sonia S. Anand, Manesh R. Patel, Warren H. Capell, Nicole Jaeger, Connie N. Hess, Eva Muehlhofer, Lloyd Haskell, Scott D. Berkowitz, Marc P. Bonaca
Topics & Concepts
MedicineSurgeryArterial diseaseRivaroxabanElectrical conduitPeripheralVascular diseaseCardiologyInternal medicineWarfarinEngineeringMechanical engineeringAtrial fibrillationPeripheral Artery Disease ManagementCardiac, Anesthesia and Surgical OutcomesRenal and Vascular Pathologies